Date
- Thursday, 29 November 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This training session for patient- and consumer-organisation representatives is focusing on the new pharmacovigilance legislation; the Pharmacovigilance Risk Assessment Committee (PRAC); risk-management plans and post-authorisation safety studies; adverse-drug-reaction reporting and signal detection; periodic safety update reports; safety referrals; and the impact of the pharmacovigilance legislation.
Documents
Agenda - Training session on the new pharmaceutical legislation, 29 November 2012
English (EN) (79.44 KB - PDF)
Presentation - Setting the scene: New European Union pharmacovigilance legislation (P. Arlett)
English (EN) (266.8 KB - PDF)
Presentation - Pharmacovigilance legislation: Our implementation journey... (F. Diafouka)
English (EN) (776.63 KB - PDF)
Presentation - Good pharmacovigilance practices (P. Bahri)
English (EN) (160.06 KB - PDF)
Presentation - Lifecycle of a new medicinal product (N. Bere)
English (EN) (128.56 KB - PDF)
Presentation - The Pharmacovigilance Risk Assessment Committee mandate, composition and tasks (R. De Lisa)
English (EN) (614.46 KB - PDF)
Presentation - How we communicate the outcome of safety reviews (M. Benstetter)
English (EN) (285.51 KB - PDF)
Presentation - Risk management (S. Blackburn)
English (EN) (1.08 MB - PDF)
Presentation - Measuring the effectiveness of risk-minimisation measures (A. Rubino)
English (EN) (330.03 KB - PDF)
Presentation - Non-interventional post-authorisation safety studies: Definition, obligations and requirements (A. Rubino)
English (EN) (466.2 KB - PDF)
Presentation - Reporting side effects of medicines (V. Newbould)
English (EN) (155.57 KB - PDF)
Presentation - Public website of side effects (V. Newbould)
English (EN) (936.74 KB - PDF)
Presentation - Signal detection and management (G. Genov)
English (EN) (2.36 MB - PDF)
Presentation - Medicinal products subject to additional monitoring (M. Arriegas)
English (EN) (106.02 KB - PDF)
Presentation - Periodic-safety-update-report procedure and concept of benefit-risk evaluation (R. Postigo)
English (EN) (804.65 KB - PDF)
Presentation - Referral procedures (A. Marcal, H. Matos and V. Seguin)
English (EN) (429.6 KB - PDF)
Presentation - Additional monitoring of medicines and side-effect reporting: Impact on the product information (C. Espinasse)
English (EN) (1.26 MB - PDF)
Presentation - European-public-assessment-report summaries (D. Glanville)
English (EN) (237.63 KB - PDF)